OPK OPKO Health, Inc.

NASDAQ
$1.64

OPKO Health, Inc. (OPK) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.07 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +18.8% since its last earnings release on July 27, 2026.

OPKO Health Beat Consensus Estimates, Raises Guidance
Monday, July 27, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.07)
Rev est $136.16M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.53

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About OPKO Health, Inc.

Opko Health Inc is a biopharmaceutical and diagnostics company. The Company is engaged in the research and development of pharmaceutical products and vaccines.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.